Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan vs metoprolol for late hypertension after repaired aortic coarctation
2006-006861-18Phase 4Active
- Sponsor
- Department of Cardiology
- Start
- Dec 2006
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) and Coarctation of the aorta (CoA) comparing Candesartan with Metoprolol (2 arms). Primary endpoint: Reduction in 24-hour systolic blood pressure at 8 weeks. Started Dec 2006; status: active.
02
Drugs
candesartanmetoprolol
03
Conditions
hypertension (HTN)Coarctation of the aorta (CoA)
Beyond the preview
Go deeper on 2006-006861-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006861-18.